Overall, the emerging scenario suggests that the relative expression levels of CXCR4 and ACKR3 and whether they are expressed in the same or distinct subpopulations of cancer or stromal cells, may have an impact on CXCL12-mediated responses, highlighting a relevant question for future research. This evidence concerns the gene CXCL12 and cancer.